Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank43
5Y CAGR-49.9%
Year-over-Year Change
Year-over-year net income growth rate
5Y CAGR
-49.9%/yr
Long-term compound
Percentile
P43
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 2.09% |
| 2024 | 11.61% |
| 2023 | -8.87% |
| 2022 | -46.28% |
| 2021 | 129.86% |
| 2020 | 66.05% |
| 2019 | -13.44% |
| 2018 | 103.95% |
| 2017 | 33.83% |
| 2016 | 40.79% |